Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells

BACKGROUND/AIMFew studies have examined the correlation between pyruvate kinase M2 (PKM2) overexpression and triple-negative breast cancer (TNBC). TNBC is considered incurable with the currently available treatments, highlighting the need for alternative therapeutic targets. MATERIALS AND METHODSPKM...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	In vivo (Athens) 2022-09, Vol.36 (5), p.2105-2115
Hauptverfasser:	LEE, JI SUN, OH, YUNMOON, LEE, JIN-SOL, PARK, JAE HYEON, SHIN, JOO-KYUNG, HAN, JOO-HEE, KIM, HYUNG SIK, YOON, SUNGPIL
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!